You have read all your free articles, to continue reading subscribe to read the rest of this content.
Novo Nordisk has entered into a definitive agreement to acquire Corvidia Therapeutics Inc., a privately held, clinical stage company focused on the research and development of transformative therapies for cardio-renal diseases. Corvidia Therapeutics’ lead candidate, ziltivekimab, a fully human Already a subscriber Login You have read all your free articles,…
AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm. The divestment includes medicines containing omeprazole marketed by AstraZeneca or its collaborators under the Acimax, Antra, MepAlready a subscriber Login You have read all your free articles, to continue…
On April 26th TFS International (TFS) completed the acquisition of the New Jersey-based Oncology and Vaccine specialist Contract Research Organization (CRO), Beardsworth Consulting Group, Inc. (BCG). In a move to expand its oncology and vaccine research services, TFS has announced the completion Already a subscriber Login You have read all…
As part of the financing of the acquisition of Rottapharm, Meda's Board of Directors has resolved to launch a rights issue of approximately SEK 2.0 billion. On 31 July 2014, Meda announced entering into an agreement to acquire the Italian specialty pharma company Rottapharm S.p.A. Completion of tAlready a subscriber…
